Drug
Hrs 6209 Letrozole
Hrs 6209 Letrozole: highest development phase Phase 3, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| HRS-6209 + Letrozole NCT07894328 | Phase 3 | Breast Cancer |
Latest
No recent events.
Follow Hrs 6209 Letrozole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.